Form 4: Humana Director Boosts Stake with RSU Acquisition

Humana Director David T. Feinberg acquired 69 restricted stock units and holds a total of 2,689 shares and RSUs, reflecting deferred compensation and reinvested dividends.

Summary

• David T. Feinberg, a Director at Humana Inc. (HUM), reported changes in his beneficial ownership.
• As of the filing, Mr. Feinberg directly owns 441 shares of Humana Common Stock.
• On September 30, 2025, Mr. Feinberg acquired 69 Restricted Stock Units (RSUs) at a price of $257.7925 per unit, as part of his director's cash fee elected to be converted into stock units.
• These 69 RSUs are deferred and will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Mr. Feinberg also holds 1,593 Restricted Stock Units from annual director's fees, deferred until his resignation and payable 1-for-1.
• Additionally, he holds 17 Restricted Stock Units from dividend payments reinvested into stock units on vested and deferred units, also payable 1-for-1.
• Following these transactions, Mr. Feinberg beneficially owns a total of 2,248 Restricted Stock Units (1,593 + 638 + 17) and 441 shares of common stock, totaling 2,689 potential shares.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction related to director compensation and dividend reinvestment. It is generally neutral, but the continued accumulation of company stock by a director can be viewed as a slightly positive signal of confidence in the company's future.

Positives

• The acquisition of restricted stock units by a director demonstrates continued alignment of management's interests with those of shareholders.
• The deferral of compensation into stock units indicates a long-term commitment to the company's performance by the director.

Future Outlook

The Restricted Stock Units acquired and held by the director are deferred and will be payable in Humana Inc. common stock on a 1-for-1 basis upon the director's resignation, indicating a long-term incentive structure.

Management Comments

• Annual Director's fee payable in stock units has been deferred at the election of the Reporting Person until his resignation of services as a director, at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's cash fee was elected to be converted into stock units, deferred at the election of the Reporting Person, and will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's dividend payment was reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan, and will be payable in Humana Inc. common stock on a 1-for-1 basis.

Industry Context

It is a common practice in publicly traded companies for directors to receive a portion of their compensation in the form of equity, such as restricted stock units, to align their interests with those of shareholders and promote long-term value creation.

Comparison to Industry Standards

• The practice of compensating directors with restricted stock units and allowing for deferral is a standard corporate governance practice across many industries, including healthcare, to align director incentives with long-term shareholder value.
• The specific value and number of units are consistent with compensation structures for directors at large-cap companies, though direct comparisons to specific competitor compensation packages are not provided in this filing.

Related Party Transactions

• The acquisition of restricted stock units by a director as part of their compensation plan constitutes a related party transaction, which is a standard and disclosed practice.

Stakeholder Impact

• Shareholders: The director's increased equity stake enhances alignment of interests, potentially leading to decisions that benefit long-term shareholder value.
• Management: The compensation structure incentivizes long-term performance and retention of key board members.

Next Steps

• The deferred Restricted Stock Units will be converted into Humana Inc. common stock on a 1-for-1 basis upon the director's resignation.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director acquired restricted stock units as part of their compensation and dividend reinvestment. Such transactions are standard practice and do not typically indicate a significant change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. It primarily reflects ongoing director compensation and alignment of interests.

Keywords

Humana, HUM, Form 4, insider transaction, director compensation, restricted stock units, equity ownership, beneficial ownership